Skip to main content
Boryung Corporation logo

Boryung Corporation — Investor Relations & Filings

Ticker · 003850 ISIN · KR7003850005 KO Manufacturing
Open in API
Filings indexed 354 across all filing types
Latest filing 2022-02-23 AGM Information
Country KR South Korea
Listing KO 003850

About Boryung Corporation

https://pharm.boryung.co.kr/eng/index.do

Boryung Corporation is a fully integrated healthcare company founded in 1957. Its core business encompasses the research, development, manufacturing, and global commercialization of pharmaceutical products, with a significant presence in the cardiovascular therapeutic area. The company is distinguished by its pioneering 'Care in Space' (CIS) initiative, which focuses on developing healthcare solutions for humans in extreme environments and leveraging space for new research opportunities. In addition to its pharmaceutical operations, Boryung functions as a healthcare investment company, fostering innovation across the health sector. The company's diverse portfolio includes prescription drugs, over-the-counter products, and a pipeline aimed at addressing future medical needs.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a 'General Meeting of Shareholders' (주주총회소집결의) issued by Boryeong Pharmaceutical. It outlines the agenda for the upcoming Annual General Meeting, including the approval of financial statements, election of directors and auditors, and dividend proposals. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of meeting details and request their votes, fitting the definition of a Proxy Solicitation & Information Statement (PSI).
2022-02-23 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Report' (영업(잠정)실적) for Boryung Pharmaceutical, detailing quarterly and cumulative financial performance (revenue, operating profit, net income) for the 4th quarter of 2021. This is a standard initial announcement of financial results, which fits the definition of an Earnings Release (ER). Q4 2021
2022-02-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea (often referred to as an 'Insider Trading' or 'Director's Dealing' report) to notify the regulator of share acquisitions or disposals by company insiders. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2022-01-07 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Boryung Pharmaceutical Co., Ltd., covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial statements, management discussion, and operational data, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-15 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Report' (영업(잠정)실적) for Boryung Pharmaceutical, detailing quarterly financial highlights such as revenue, operating profit, and net income. It is a standard initial announcement of financial results, which fits the definition of an Earnings Release (ER). Q3 2021
2021-10-27 Korean
투자판단관련주요경영사항
M&A Activity Classification · 100% confidence The document is a regulatory filing from Boryung Pharmaceutical regarding the acquisition of rights to the 'Zyprexa' brand from Eli Lilly. It details the contract terms, financial impact, and strategic rationale (LBA strategy). This type of disclosure, which reports a significant business transaction or material event to the public and regulators, is best classified as a general regulatory filing (RNS) as it does not fit into specific categories like M&A (which usually refers to corporate mergers/takeovers) or other specialized reports.
2021-10-21 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.